Literature DB >> 341225

Experimental atherosclerosis in rabbits: platelet aggregation, thromboxane A2 generation and anti-aggregatory potency of prostacyclin.

A Zmuda, A Dembinska-Kiec, A Chytkowski, R J Gryglewski.   

Abstract

Experimental atherosclerosis in rabbits was associated with increased aggregation of their platelets to arachidonic acid, and with increased generation of thromboxane A2 by their platelet-rich plasma. A heightened susceptibility of platelets to the anti-aggregatory action of prostacyclin against the ADP-induced aggregation was also observed. It is concluded that in advance atherosclerosis the platelet system is hypersensitive to biologically active metabolites of arachidonic acid.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 341225     DOI: 10.1016/0090-6980(77)90283-0

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  8 in total

1.  Relation between fibrinolytic activity and prostacyclin generation of atherosclerotic artery and dacron prosthetic graft.

Authors:  H Sinzinger; K Silberbauer; M Winter; W Auerswald
Journal:  Experientia       Date:  1979-06-15

2.  Cardiovascular effects of acute hypercholesterolemia in rabbits. Reversal with lovastatin treatment.

Authors:  J A Osborne; P H Lento; M R Siegfried; G L Stahl; B Fusman; A M Lefer
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

3.  A triple test for screening biological activity of prostacyclin analogues.

Authors:  R J Gryglewski; K C Nicolaou
Journal:  Experientia       Date:  1978-10-15

4.  Effects of dipyridamole in vivo on ATP and cAMP content in platelets and arterial walls and on atherosclerotic plaque formation.

Authors:  A Dembinska-Kiec; W Rücker; P S Schönhöfer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-10       Impact factor: 3.000

5.  Renal vasoconstriction caused by short-term cholesterol feeding is corrected by thromboxane antagonist or probucol.

Authors:  R Kaplan; H S Aynedjian; D Schlondorff; N Bank
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

6.  Is the variation in the susceptibility of various species to atherosclerosis due to inborn differences in prostacyclin (PGI2) formation.

Authors:  H Sinzinger; P Clopath; K Silberbauer; M Winter
Journal:  Experientia       Date:  1980-03-15

7.  Thromboxane B2 biosynthesis and phospholipids hydrolysis in platelets from hypercholesterolemic rabbits.

Authors:  H Kawaguchi; T Ishibashi; Y Imai
Journal:  Lipids       Date:  1981-01       Impact factor: 1.880

8.  Increased severity of acute myocardial ischemia in experimental atherosclerosis.

Authors:  J A Osborne; R K Mentley; A M Lefer
Journal:  Heart Vessels       Date:  1987       Impact factor: 2.037

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.